Johnson & Johnson said on Monday it had filed a lawsuit against Samsung Bioepis for breaching its contract agreement with the ...

Mutations in BRCA1 do not appear to contribute significantly to the risk of prostate cancer progression, according to DNA ...

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

HYDERABAD: Reiterating the state government’s goal to make Hyderabad the world’s “China Plus One” destination, Chief Minister ...

Hyderabad: US-based biopharma giant Amgen flagged off its first India investment with a new technology and innovation centre ...

The site is expected to accelerate Amgen’s digital capabilities through artificial intelligence and data science to further ...

US-based biopharma giant on Monday opened its new technology and innovation centre in Hyderabad with its CEO Robert Bradway ...

Amgen, a leading American biopharmaceutical company, is set to invest $200 million in a new Technology and Innovation Centre.

Global biotech leader Amgen opened its $200 million technology and innovation centre in Hyderabad, a facility that will help ...

Amgen invests $200M in India's tech center to leverage AI for drug development. The U.S. FDA seeks to rehire 300 staff ...

Amgen (AMGN) plans to invest about $200M this year in its new technology center in southern India, with further investments planned, Reuters’ ...

Amgen (NASDAQ: AMGN) is investing $200 million in its new technology and innovation center in Hyderabad, India, to enhance AI ...